In contrast, PRIMO-FRL dynamically adjusts insulin dosing through real-time learning and explicitly incorporates clinical goals—including hypoglycemia avoidance, glycemic stability, and insulin efficiency—into its optimization framework. Here, INS is linked to Hypoglycemia.